WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | - | - | - | - | - |
What is the latest Contingent Liabilities ratio of WINDLAS BIOTECH ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
| Mar2021 | - |
How is Contingent Liabilities of WINDLAS BIOTECH Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | 0 | |
| Mar2021 | - | - | |
Compare Contingent Liabilities of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹2,026.8 Cr | 0.3% | 4% | 0.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹409,626.0 Cr | -0.3% | 6% | -10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,669.0 Cr | 3.9% | 18.6% | 14.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹122,793.0 Cr | -1% | -1.2% | 8.7% | Stock Analytics | |
| CIPLA | ₹122,103.0 Cr | -5.2% | NA | 2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,857.4 Cr | -6.8% | -2.1% | -8.4% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | 0.3% |
4% |
0.6% |
| SENSEX | -0.9% |
4.6% |
5% |
You may also like the below Video Courses